Report cover image

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

Published Jul 18, 2019
Length 103 Pages
SKU # KLI16036801

Description

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.

Test Segments: Market Sizing and ForecastsThere are several segments where testing at the molecular level has thrived, including the following:
  • HPV Testing
  • CT/NG Testing
  • Molecular Hepatitis Testing
  • HIV Testing
  • Hospital Acquired Infections and Sepsis Testing
  • Respiratory Diseases Testing
  • Mycobacteria/Tuberculosis Testing
The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition.

Regional Distribution

For each of these segments, the report provides a breakout for the following regions:
  • North America
  • Europe
  • Asia Pacific
  • Other
Company Profiles

Companies covered in this report include:
  • Abbott
  • bioMérieux
  • Bio-Rad
  • Cepheid
  • Meridian
  • Qiagen
  • Quidel
  • Roche

Table of Contents

103 Pages
    • The Global Infectious Disease Molecular Diagnostics Market
    • Test Segments
    • Emerging Trends Influencing the Market Landscape
    • Molecular POC: Upstart Competitors
    • Prospects for Molecular POC Testing for Infectious Diseases Diagnostics
    • Increased Presence of STDs
    • Lyme Disease: Major IVD Leaps in with Molecular Solutions
    • New Fungal Infection Spotlights Mass Spec and Sequencing
    • Updated Influenza Guidelines from the Infectious Diseases Society of America
    • PCR-based Assay for Diagnosis of Bacteremia Beats Blood Cultures in Study
    • Meridian Acquires GenePOC
    • T2Bacteria Study Demonstrates Worth in Recent Study
    • Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
    • Reimbursement Environment for Molecular Diagnostics
    • New Project Uses Sequencing for TB Diagnosis in Emerging Nations
    • Growing Microhospital Business Beckons Clinical Labs
    • New Eight Bacteria Gram-Negative Test Cleared by FDA
    • Clinical Utility of Molecular Diagnostics
    • AI Assisting with Molecular Colorectal Diagnosis
    • Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
    • Market Analysis - Global
    • Abbott Diagnostics
    • Becton, Dickinson & Co. (BD)
    • bioMérieux
    • Bio-Rad Laboratories
    • Danaher (Cepheid and Leica Biosystems)
    • Meridian Bioscience Inc
    • QIAGEN N.V.
    • Quidel Corporation
    • Roche Diagnostics
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.